SLC7A11 and hepatocellular carcinoma: SLC7A11 promotes HCC metastasis by increasing programmed death ligand 1 and colony-stimulating factor 1, and its high expression is linked to poor tumor differentiation and an advanced tumor-node-metastasis stage 25.